NCT04657445View on ClinicalTrials.gov

EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

June 30, 2021

Conditions
Olfactory and Taste Dysfunction in SARS-CoV2 Infection
Interventions
DIAGNOSTIC_TEST

visual analogue scale

A visual analog scale (VAS) is a measurement device used to quantify a subjective experience.

Trial Locations (1)

45500

University General Hospital of Ioannina, Ioannina

All Listed Sponsors
lead

University Hospital, Ioannina

OTHER

NCT04657445 - EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY | Biotech Hunter | Biotech Hunter